Balance Sheet Data

Alnylam Pharmaceuticals, Inc. (ALNY)

$154.965

-2.69 (-1.70%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 1,536.161,874.392,435.562,192.412,439.3810,875.9018,888.5732,804.4956,972.7898,946.75
Total Cash (%)
Account Receivables 43.01102.41198.57237.96327.79665.141,155.182,006.243,484.326,051.34
Account Receivables (%)
Inventories 56.3592.30122.70128.9689.15483.97840.541,459.792,535.274,403.10
Inventories (%)
Accounts Payable 49.8851.9773.4398.0955.52345.68600.361,042.661,810.833,144.93
Accounts Payable (%)
Capital Expenditure -140.16-70.36-76.37-72.06-62.21-618.86-1,074.80-1,866.64-3,241.87-5,630.28
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.